ARTNATURE INC. (7823) Stock Price

Art Nature's primary business is the manufacturing and sales of custom-made wigs. The company measures customers' head shapes using a 3D scanning system and outsources manufacturing to its Philippine subsidiaries, AN Philippines and ANMP. Art Nature centrally purchases the main raw materials—human hair and synthetic hair—and provides them free of charge to its subsidiaries.

Completed custom-made wigs are sold through Art Nature's 282 domestic stores. To diversify production locations and mitigate risk, the company established ANBD in Bangladesh and is preparing for a new factory to commence operations in 2026. This initiative aims to enhance manufacturing capacity and distribute operational risk.

Ready-made wigs for women are manufactured by AN Philippines, ANMP, and external partners in Asia, and are sold through 90 Julia Oje stores and 37 NAO-ART stores domestically. This product strategy serves a broad customer base.

Art Nature operates both domestically and internationally. Domestically, the company runs AN Tomo no Kai, which conducts prepaid specific transaction services, and Art Mikawaya, which expands the entertainment wig business. Internationally, the company operates through ANSG in Singapore, ANMY in Malaysia, and ANTH in Thailand.

Additionally, Art Nature has expanded into new business areas. In 2019, it acquired NAO-ART as a subsidiary, entering the relatively affordable wig market. The company also launched "LABOMO Hair Grow Minoxidil 5" as a pharmaceutical sales product, and established Art Medical in 2020 to support healthcare-related services.

Art Nature's management philosophy is to provide the highest quality products and best-in-class service to customers with hair-related concerns. To realize this vision, the company is strengthening product development capabilities, improving production systems, and enhancing service delivery in sales operations. The company also aims to build stakeholder trust through strengthened compliance frameworks and proactive disclosure of corporate information.

Under its medium-term management plan "Art Nature Advance Plan," the company seeks to establish a top-brand position in the hair care industry and expand into new business areas related to "beauty and health." Specifically, the company has set targets to improve revenue, operating profit margin, and ROE while pursuing efficient management. For the fiscal year ending March 2026, the company projects revenue of 47,623 million yen and operating profit of 2,778 million yen.

Art Nature prioritizes increasing its customer base both domestically and internationally. In the custom-made wig business, the company is improving customer satisfaction and promoting repeat orders. In the ready-made wig business for women, the company is unifying its sales structure to drive business expansion. The company is also focusing on expanding distribution channels through mail-order operations and overseas markets.

The company places significant emphasis on developing new business areas, including lower-priced wig products, pharmaceutical sales, and medical support services. Through M&A activities and new business launches both domestically and internationally, the company is expanding its portfolio in "beauty and health" related sectors to achieve further growth.

Securing and developing talent is also a key strategy. To consistently recruit high-caliber personnel, the company is diversifying recruitment channels and expanding hiring scope. The company is also promoting diversity management and work style reforms to enable employees to perform at their best. These initiatives aim to improve employee retention and enhance workplace vitality.